Clarissa graduated from Balliol College, Oxford, with a first class degree in Chemistry. She joined Carpmaels & Ransford as a Trainee Patent Attorney in 2018, working in both the Chemistry and Life Sciences Pharmaceutical teams.
Clarissa’s final year Master’s project focussed on using ultra-high performance liquid chromatography coupled to mass spectrometry to investigate changes in the metabolism of an LN18 glioblastoma cell line, with and without a transfected isocitrate dehydrogenase 1 (IDH1) mutation, when exposed to metformin and phenformin. These biguanide drugs are used for the treatment of type 2 diabetes but are also reported to display anti-tumorigenic properties.
Outside of work, Clarissa has a keen interest in food and travel and particularly enjoys all watersports, especially slalom waterskiing.
- MChem (University of Oxford)